scispace - formally typeset
S

Sergio Ricci

Researcher at University of Pisa

Publications -  87
Citations -  17024

Sergio Ricci is an academic researcher from University of Pisa. The author has contributed to research in topics: Sorafenib & Cancer. The author has an hindex of 28, co-authored 87 publications receiving 14757 citations. Previous affiliations of Sergio Ricci include Bayer.

Papers
More filters
Journal ArticleDOI

Safety and antitumor efficacy of 153Sm-EDTMP and docetaxel administered sequentially to patients with metastatic castration-resistant prostate cancer

TL;DR: Prior administration of 153Sm-EDTMP does not cause additional toxicities for subsequent treatment with docetaxel and does not reduce the antitumor efficacy of the latter, which justifies further investigations on the possible synergistic effects of combined strategies with the two agents.
Journal ArticleDOI

Phase II study of oral doxifluridine in elderly patients with advanced non-small-cell lung cancer.

TL;DR: It is demonstrated that a home therapy with oral doxifluridine in elderly NSCLC patients is feasible and well tolerated and should encourage further studies.
Journal Article

Off-label use of sunitinib in patients with advanced epithelial thyroid cancer: a retrospective analysis

TL;DR: Sunitinib is a novel tyrosine kinase inhibitor, approved in 2006 by Food and Drug Administration for the treatment of advanced renal cell and gastrointestinal stromal tumors as mentioned in this paper.
Journal ArticleDOI

Supportive care and not only palliative care in the route of cancer patients.

TL;DR: Supportive care and palliative care share the common goal of providing the best possible quality of life by maximizing patient’s comfort and minimizing suffering, but despite the strong similarities, the differences are not only in terms of semantic definition.